Amyloid negativity in patients with clinically diagnosed Alzheimer disease and MCI.

@article{Landau2016AmyloidNI,
  title={Amyloid negativity in patients with clinically diagnosed Alzheimer disease and MCI.},
  author={Susan M. Landau and Andy Horng and Allison Fero and William J. Jagust},
  journal={Neurology},
  year={2016},
  volume={86 15},
  pages={
          1377-1385
        }
}
OBJECTIVE To examine the clinical and biomarker characteristics of patients with amyloid-negative Alzheimer disease (AD) and mild cognitive impairment (MCI) from the Alzheimer's Disease Neuroimaging Initiative (ADNI), a prospective cohort study. METHODS We first investigated the reliability of florbetapir- PET in patients with AD and patients with MCI using CSF-Aβ1-42 as a comparison amyloid measurement. We then compared florbetapir- vs florbetapir+ patients with respect to several AD… CONTINUE READING

Connections & Topics

Mentioned Connections BETA
Amyloid negativity in patients with clinically diagnosed Alzheimer disease and MCI . OBJECTIVE .
To examine the clinical and biomarker characteristics of patients with amyloid - negative Alzheimer disease ( AD ) and mild cognitive impairment ( MCI ) from the Alzheimer 's Disease Neuroimaging Initiative ( ADNI ) , a prospective cohort study .
To examine the clinical and biomarker characteristics of patients with amyloid - negative Alzheimer disease ( AD ) and mild cognitive impairment ( MCI ) from the Alzheimer 's Disease Neuroimaging Initiative ( ADNI ) , a prospective cohort study .
To examine the clinical and biomarker characteristics of patients with amyloid - negative Alzheimer disease ( AD ) and mild cognitive impairment ( MCI ) from the Alzheimer 's Disease Neuroimaging Initiative ( ADNI ) , a prospective cohort study .
To examine the clinical and biomarker characteristics of patients with amyloid - negative Alzheimer disease ( AD ) and mild cognitive impairment ( MCI ) from the Alzheimer 's Disease Neuroimaging Initiative ( ADNI ) , a prospective cohort study .
To examine the clinical and biomarker characteristics of patients with amyloid - negative Alzheimer disease ( AD ) and mild cognitive impairment ( MCI ) from the Alzheimer 's Disease Neuroimaging Initiative ( ADNI ) , a prospective cohort study .
To examine the clinical and biomarker characteristics of patients with amyloid - negative Alzheimer disease ( AD ) and mild cognitive impairment ( MCI ) from the Alzheimer 's Disease Neuroimaging Initiative ( ADNI ) , a prospective cohort study .
To examine the clinical and biomarker characteristics of patients with amyloid - negative Alzheimer disease ( AD ) and mild cognitive impairment ( MCI ) from the Alzheimer 's Disease Neuroimaging Initiative ( ADNI ) , a prospective cohort study .
To examine the clinical and biomarker characteristics of patients with amyloid - negative Alzheimer disease ( AD ) and mild cognitive impairment ( MCI ) from the Alzheimer 's Disease Neuroimaging Initiative ( ADNI ) , a prospective cohort study .
To examine the clinical and biomarker characteristics of patients with amyloid - negative Alzheimer disease ( AD ) and mild cognitive impairment ( MCI ) from the Alzheimer 's Disease Neuroimaging Initiative ( ADNI ) , a prospective cohort study .
Amyloid negativity in patients with clinically diagnosed Alzheimer disease and MCI . OBJECTIVE .
To examine the clinical and biomarker characteristics of patients with amyloid - negative Alzheimer disease ( AD ) and mild cognitive impairment ( MCI ) from the Alzheimer 's Disease Neuroimaging Initiative ( ADNI ) , a prospective cohort study .
To examine the clinical and biomarker characteristics of patients with amyloid - negative Alzheimer disease ( AD ) and mild cognitive impairment ( MCI ) from the Alzheimer 's Disease Neuroimaging Initiative ( ADNI ) , a prospective cohort study .
To examine the clinical and biomarker characteristics of patients with amyloid - negative Alzheimer disease ( AD ) and mild cognitive impairment ( MCI ) from the Alzheimer 's Disease Neuroimaging Initiative ( ADNI ) , a prospective cohort study .
All Topics